Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Slevin

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Acta Oncologica (Stockholm, Sweden)|April 10, 2018
Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismusChristina Hague, William Beasley, Kate Garcez, et al.
Head & Neck|December 19, 2013
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neckDavid J Thomson, Priyamal Silva, Kim Denton, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centersC Robertson, A G Robertson, J H Hendry, et al.
Plos One|March 29, 2018
Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapyNatalie M Lowe, Lucy E Kershaw, Jonathan M Bernstein, et al.
European Journal of Nuclear Medicine|March 18, 1999
Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?R A Cooper, R A Cowan, S E Owens, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 31, 2012
Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapyC M Douglas, J M Bernstein, V E Ormston, et al.
Acta Oncologica (Stockholm, Sweden)|October 4, 2014
Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinomaDavid J Thomson, Kean F Ho, Linda Ashcroft, et al.
Analytical Biochemistry|April 3, 2008
Surface plasmon resonance-enhanced fluorescence implementation of a single-step competition assay: demonstration of fatty acid measurement using an anti-fatty acid monoclonal antibody and a Cy5-labeled fatty acidMargarida M L M Vareiro, Isabelle Tranchant, Sandra Maplin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 10, 2018
Analysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver MetastasesJ White, G Carolan-Rees, M Dale, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)David J Thomson, Nick J Slevin, Helen Baines, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|April 10, 2018
Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismusChristina Hague, William Beasley, Kate Garcez, et al.
Head & Neck|December 19, 2013
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neckDavid J Thomson, Priyamal Silva, Kim Denton, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centersC Robertson, A G Robertson, J H Hendry, et al.
Plos One|March 29, 2018
Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapyNatalie M Lowe, Lucy E Kershaw, Jonathan M Bernstein, et al.
European Journal of Nuclear Medicine|March 18, 1999
Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?R A Cooper, R A Cowan, S E Owens, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 31, 2012
Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapyC M Douglas, J M Bernstein, V E Ormston, et al.
Acta Oncologica (Stockholm, Sweden)|October 4, 2014
Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinomaDavid J Thomson, Kean F Ho, Linda Ashcroft, et al.
Analytical Biochemistry|April 3, 2008
Surface plasmon resonance-enhanced fluorescence implementation of a single-step competition assay: demonstration of fatty acid measurement using an anti-fatty acid monoclonal antibody and a Cy5-labeled fatty acidMargarida M L M Vareiro, Isabelle Tranchant, Sandra Maplin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 10, 2018
Analysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver MetastasesJ White, G Carolan-Rees, M Dale, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 2023
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)David J Thomson, Nick J Slevin, Helen Baines, et al.
Pageof 12